FORMULATION OF ANDROGRAPHOLIDE TRANSFERSOMES GEL FOR TRANSDERMAL DELIVERY: A PRELIMINARY STUDY
Objective: A transfersome is a drug delivery system that offers increased penetration for the transdermal delivery of drugs. The aim of this study was
to assess the application of transfersomes for transdermal delivery of andrographolide.
Methods: The development of andrographolide transfersomes for transdermal delivery was conducted in two steps. The first step involved varying
ratios of Span 80 and phospholipids to investigate the effect on transfersome deformability using four formulations (P1–P4). Afterward, a second step
involved varying ratios of andrographolide in transfersomes to investigate the influence on entrapment efficiency using four formulations (F1–F4).
The selected transfersomes were then formulated into a gel dosage form. An in vitro penetration study was conducted by comparing the penetration
fluxes of the transfersome and non-transfersome andrographolide gels using Franz diffusion cells.
Results: The results showed that formulation F4 had an entrapment efficiency of 97.02±0.01% and particle size (DV-average) of 524.02 nm. An in vitro
penetration study of the andrographolide transfersome gels showed two phases of penetration, with a marked increase in both fluxes. In the first
phase, penetration flux was 23.26±2.34 and 1.28±0.82 μg/cm2·h for the transfersome and non-transfersome andrographolide gels, respectively.
Conclusion: The results showed that the transfersome gel is a promising dosage system for transdermal delivery of andrographolide.
activities and clinical effects. Altern Med Rev 2011;16:66-77.
2. Banerjee M, Chattopadhyay S, Choudhuri T, Bera R, Kumar S,
Chakraborty B, et al. Cytotoxicity and cell cycle arrest induced by
andrographolide lead to programmed cell death of MDA-MB-231
breast cancer cell line. J Biomed Sci 2016;23:40.
3. Ye L, Wang T, Tang L, Liu W, Yang Z, Zhou J, et al. Poor oral
bioavailability of a promising anticancer agent andrographolide is due
to extensive metabolism and efflux by P-glycoprotein. J Pharm Sci
4. Korinth G, Wellner T, Schaller KH, Drexler H. Potential of the octanolwater
partition coefficient (logP) to predict the dermal penetration
behaviour of amphiphilic compounds in aqueous solutions. Toxicol Lett
5. Yao Y, Liao QF, Zeng LY, Zhang L, Ma Y, Zeng YE. Determination
of apparent oil-water partition coefficient of andrographolide and
dehydroandrographolide and effect of pH on them. Zhong Yao Cai
6. Chaudhary H, Kohli K, Kumar V. Nano-transfersomes as a novel carrier
for transdermal delivery. Int J Pharm 2013;454:367-80.
7. Gupta A, Aggarwal G, Singla S, Arora R. Transfersomes: A novel
vesicular carrier for enhanced transdermal delivery of sertraline:
Development, characterization, and performance evaluation. Sci Pharm
8. Qushawy M, Nasr A, Abd-Alhaseeb M, Swidan S. Design, optimization
and characterization of a transfersomal gel using miconazole nitrate for
the treatment of Candida skin infections. Pharmaceutics 2018;10:e26.
9. Luthfiah A, Sagita E, Iskandarsyah I. Physical stability testing
of p-synephrine prepared as transfersome gel. Int J Appl Pharm
10. van den Bergh BA, Wertz PW, Junginger HE, Bouwstra JA. Elasticity
of vesicles assessed by electron spin resonance, electron microscopy
and extrusion measurements. Int J Pharm 2001;217:13-24.
11. El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. Role of edge
activators and surface charge in developing ultradeformable vesicles
with enhanced skin delivery. Int J Pharm 2010;397:164-72.
12. Surini S, Sarah S, Djajadisastra J. Formulation and in vitro penetration
study of transfersomes gel containing gotu kola leaves extract (Centella
asiatica L. Urban). J Young Pharm 2017;9:483-6.
13. Sajeeb BK, Kumar U, Halder S, Bachar SC. Identification and
quantification of andrographolide from Andrographis paniculata
(Burm. f.) wall. ex nees by RP-HPLC method and standardization of its
market preparations. J Pharm Sci 2015;14:71-8.
14. Sinha J, Mukhopadhyay S, Das N, Basu MK. Targeting of liposomal
andrographolide to L. donovani infected macrophages in vivo. Drug
15. Setyawati DR, Surini S, Mardliyati E. Optimization of luteolin-loaded
transfersome using response surface methodology. Int J Appl Pharm
16. Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM. Liposomes
as carriers for dermal delivery of tretinoin: In vitro evaluation of
drug permeation and vesicle-skin interaction. J Control Release
17. Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T.
Characterization and in vitro skin permeation of meloxicam-loaded
liposomes versus transfersomes. J Drug Deliv 2011;2011:418316.
18. Jain S, Jain P, Umamaheshwari RB, Jain NK. Transfersomes--a novel
vesicular carrier for enhanced transdermal delivery: Development,
characterization, and performance evaluation. Drug Dev Ind Pharm
19. Rowe R, Sheskey P, Quinn M, editors. Handbook of Pharmaceutical
Excipients. Vol. 6. London: Pharmaceutical Press; 2009.
20. Rajan R, Jose S, Mukund VP, Vasudevan DT. Transferosomes a
vesicular transdermal delivery system for enhanced
This work is licensed under a Creative Commons Attribution 4.0 International License.